Different Uptake of Tc-99m ECD and Tc-99m HMPAO in the Normal Brains: Analysis by Statistical Parametric Mapping |
Kim, Euy-Neyng
(Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea)
Jung, Yong-An (Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea) Sohn, Hyung-Sun (Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea) Kim, Sung-Hoon (Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea) Yoo, Ie-Ryung (Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea) Chung, Soo-Kyo (Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea) |
1 | Greenberg JH, Lassen NA. Characterization ofTc-99m bicisate as an agent for the measurementof cerebral blood flow with SPET. J CerebBlood Flow Metab 1994;14: S36-43. |
2 | Walovitch RC, Hill TC, Garrity ST, CheesmanEH, Burgess BA, O'Leary DH, et al:Characterization of Tc-99m-L,L-ECD for brainperfusion imaging. Part 1. Pharmacology ofTc-99m-ECD in nonhuman primates. J NuclMed 1989;30:1902-10. |
3 | Van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, et al. Comparison of Tc-99m-HMPAO and Tc-99m-ECD cerebral SPET images in Alzheimer's disease. J Nucl Med 1996;37:1749-55. |
4 | Rieck H, Adelwohrer C, Lungenschmid K,Deisenhammer E. Discordance of Tc-99mHMPAOand Tc-99m-ECD SPET in herpessimplex encephalitis. J Nucl Med 1998;39:1508-10. |
5 | Lee JD, Kim DI, Ryu YH, Whang GJ, Park CI,Kim DG, et al. Tc-99m-ECD brain SPET incerebral palsy: comparison with MR!. J NuclMed 1998;39:619-23. |
6 | Friston KJ, Holmes AP, Worsley KJ. Statisticalparametric maps in functional imaging: a generallinear approach. Human Brain Mapping 1995;2:190-210. |
7 | Friston KJ, Ashburner CD, Frith CD. Spatialregistration and normalization of images. HumanBrain Mapping 1995:3;165- 89. |
8 | Patterson JC, Early TS, Martin A, Walker MZ,Russell JM, Villanueva-Meyer H, et al. SPETimage analysis using statistical parametricmapping: comparison of Tc-99m- HMPAO and Tc-99m-ECD. J Nucl Med 1997;38:1721-5. |
9 | Hyun IY, Lee IS, Rha JR, Lee IK, Ha CK, LeeDS. Different uptake of Tc-99m ECD andTc-99m HMPAO in the same brains: analysis bystatistical parametric mapping. Eur J Nucl Med2001;28:191-7. |
10 | Leveille J, Demonceau G, Walovitch RC.Intrasubject comparison between Tc-99m- ECDand Tc-99m-HMPAO in healthy human subjects.J Nucl Med 1992;33:480-4. |
11 | Matsuda H, Li YM, Higashi S, Sumiya H, TsujiS, Kinuya K et al. Comparative SPECT study ofstroke using Tc-99m ECD, 123 I-IMP andTc-99m HMPAO. Clin Nucl Med 1993;18:754-8. |
12 | Koyama M, Kawashima R, Ito H, Ono S, SatoK, Goto R, et al. SPECT imaging of normalsubjects with technetium-99m- HMPAO andtechnetium-99m-ECD. J Nucl Med 1997;38:587-92. |
13 | Asenbaum S, Brucke T, Pirker W, Pietrzyk U,Podreka I. Imaging of cerebral blood flow withTc-99m-HMPAO and Tc--99m-ECD: a comparison.J Nucl Med 1998;39:613-8. |
14 | Oku N, Matsumoto M, Hashikawa K, MoriwakiH, Ishida M, Seike Y, et al. Intra-individualdifferences between Tc-99m-HMPAO and Tc99m-ECD in the normal medial temporal lobe. JNucl Med 1997;28:1109-1l. |
15 | Pupi A, Castagnoli A, De Cristofaro MT,Bacciottini L, Petti AR. Quantitative comparisonbetween Tc-99m HMPAO and Tc-99m ECD:measurement of arterial input and brainretention. Eur J Nucl Med 1994;21:124-30. |
16 | Friberg L, Andersen AR, Lassen NA, Holm S,Dam M. Retention of Tc-99m bicisate in thehuman brain after intracarotid injection. J CerebBlood Flow Metab 1994;14:S19-27. |
17 | Perry TL, Berry K, Hansen S, Diamond S, MokC. Regional distribution of amino acids inhuman brain obtained at autopsy. J Neurochem1971;18:513-9. |
18 | Heiss WD, Herholz K, Podreka I, Neubauer I,Pietrzyk U. Comparison of [99m Tcl HMPAOSPET with es Fjfluoromethane PET in cerebrovasculardisease. J Cereb Blood Flow Metab1990;10:687-97. |